Nu-V CO₂ intimate rejuvenation
CO₂ vaginal rejuvenation and vaginal laser treatment
Private, assessment-led care for women researching vaginal dryness, discomfort, menopause-related changes, postpartum concerns or bladder leakage. Nu-V may be one option where clinically appropriate after consultation and assessment.
- CQC registered Regulated and inspected
- 4.8 / 5 From 3,500+ reviews
- Assessment-led Suitability before treatment
What is Nu‑V CO₂ vaginal rejuvenation?
Nu‑V CO₂ vaginal rejuvenation is the name used by The Women’s Health Clinic for an assessment-led, non-surgical CO₂ vaginal laser procedure involving selected internal vaginal tissue after consultation and clinical assessment. External vulval treatment may be discussed as an optional additional treatment where clinically appropriate.
It is one specific method within the wider vaginal rejuvenation field. It is not another name for the whole category, and it does not describe every treatment used for intimate health concerns.
What “CO₂” describes
CO₂ refers to the carbon dioxide laser technology used to deliver energy according to the treatment protocol.
The term does not mean that every CO₂ device, setting, protocol, treatment area, clinical indication or body of evidence is identical.
Internal treatment with an optional external addition
The vagina is the internal canal. The vulva is the external intimate area, including the labia and vaginal opening.
Standard Nu‑V treatment is internal vaginal treatment. Selected external vulval tissue may be treated as an optional additional treatment where this is clinically appropriate, assessed separately and included in the consented plan.
What the name does not establish
“CO₂ intimate rejuvenation” is not a diagnosis, clinical indication, guarantee of suitability or promise of improvement.
The name also does not establish how many sessions may be discussed, whether maintenance will be appropriate or whether another pathway would be more suitable.
Method definition
A precise way to describe Nu‑V
Nu‑V CO₂ vaginal rejuvenation is an assessment-led, non-surgical internal vaginal laser treatment offered by The Women’s Health Clinic. Where clinically appropriate, selected external vulval treatment may be added as an optional extra under a separate, consented clinical plan.
Terms patients may encounter online
These phrases are often used interchangeably in online searches. On this page, they are explained in relation to the Nu‑V CO₂ method only. They should not be interpreted as interchangeable with every vaginal rejuvenation procedure or every form of intimate healthcare.
The boundary between information and recommendation
This page explains what Nu‑V is, how the pathway is organised and what questions should be considered. A recommendation can only follow an individual consultation, appropriate assessment and informed discussion of the evidence, risks, limitations and alternatives.
Could Nu-V be relevant to what you are experiencing?
Women often discover CO₂ vaginal laser treatment while researching a personal change rather than a treatment name. The concerns below explain why someone may ask for an assessment; they do not confirm that Nu-V is suitable.
Similar symptoms can arise from hormonal, pelvic-floor, structural, dermatological, infectious or other medical causes. The clinical context determines the appropriate next step.
Vaginal dryness, soreness or reduced lubrication
Dryness, irritation, burning, tissue fragility or reduced lubrication may occur around menopause, during breastfeeding, after some medical treatments or for other reasons.
Assessment should consider established medical and conservative options as well as whether an energy-based procedure has any appropriate role.
Read about vaginal dryness assessmentChanges during perimenopause or after menopause
Hormonal change can affect the vagina, vulva, bladder and urethra. Women may notice dryness, irritation, altered comfort, urinary symptoms or changes in confidence.
Menopause care, lubricants, moisturisers, vaginal oestrogen where suitable and investigation of other causes should be discussed. CO₂ laser treatment is not automatically the next step.
Explore menopause assessment and carePostpartum change or a feeling of vaginal laxity
Some women notice changes in comfort, support, sensation or how the vaginal area feels after birth, tearing, episiotomy or more than one delivery.
Assessment helps distinguish superficial tissue concerns from pelvic-floor weakness, scar-related discomfort, muscle separation, prolapse or structural change that CO₂ treatment cannot repair.
Read about vaginal laxity assessmentDiscomfort during intimacy
Pain or discomfort during intimacy is a symptom rather than a diagnosis. Possible causes include hormonal change, pelvic-floor tension, infection, vulval skin disease, scarring or another condition.
The cause should be understood before any vaginal laser treatment is considered.
Read about painful intercourse assessmentMild bladder leakage concerns
Urinary leakage can have different causes and may require pelvic-floor assessment, conservative treatment, medical review or specialist investigation.
Nu-V should not be presented as a universal or guaranteed treatment for stress urinary incontinence.
Read about urinary incontinence assessmentNot sure what is causing the change
You do not need to diagnose yourself or decide on a treatment before contacting the clinic. You can describe what has changed in your own words.
The appropriate route may involve Nu-V, menopause care, pelvic-floor support, investigation, treatment of another condition or no procedure at all.
Request a confidential consultationImportant distinction
A reason for enquiring is not an indication for treatment
Search phrases such as “laser for vaginal dryness”, “laser vaginal tightening” or “CO₂ laser after menopause” describe what a woman is researching. They do not establish diagnosis, suitability or an expected result.
Before Nu-V is discussed, the clinician may need to consider:
How suitability for Nu‑V CO₂ treatment is assessed
Assessment reviews the presenting concern, possible causes, relevant medical history, screening context, treatment objectives and whether another route should come first.
Hormonal and medical context
Dryness, irritation and tissue fragility may be associated with menopause, breastfeeding, medication, cancer treatment or other medical factors.
The relevant medical and conservative options should be considered before deciding whether an energy-based procedure has a role.
Pelvic-floor and structural context
A feeling of looseness, pressure or leakage may involve muscle function, fascial support, prolapse or childbirth-related injury.
CO₂ treatment does not perform pelvic-floor strengthening or repair significant structural separation.
Vulval, infectious and other causes
Pain, burning, irritation or tissue change can also arise from infection, inflammatory skin disease, scarring, lesions or another condition requiring diagnosis.
An energy-based treatment should not be used to bypass investigation of an unexplained symptom.
When treatment may need to be delayed, avoided or referred
Nu‑V may not be appropriate, or further review may be required first, where there is:
Possible outcome 1
Nu‑V remains an option for discussion
The findings may support an informed conversation about the procedure, its limited treatment objectives, risks and uncertainties.
Possible outcome 2
Another pathway should come first
Medical treatment, menopause care, pelvic-floor support, investigation or treatment of another condition may be the more appropriate first step.
Possible outcome 3
CO₂ treatment is not recommended
Where the method does not match the clinical concern, we explain why and discuss an alternative or onward referral where appropriate.
Empowering Women's Intimate Health: NuV Laser Treatment & Success Stories with Dr. Farzana Khan
"I Felt Juicy Again": A Real Conversation on Menopause & Intimacy | EmpowerHer EP 01
Having a Nu-V 'Vagina Facelift' Changed My Life for the Better ITV This Morning
Sara Carson BBC Radio 2 21112017
What CO₂ vaginal laser treatment is intended to do
CO₂ laser technology delivers controlled energy to selected tissue. The intended biological response is different from direct muscle strengthening, surgical tightening or structural repair.
Intended tissue response
The procedure creates a controlled thermal effect in selected mucosal or external tissue. This is intended to initiate a healing and remodelling response.
That mechanism does not prove that an individual symptom will improve, and it does not establish that the method is appropriate for every clinical indication.
Device type, settings, treatment area, protocol, patient selection and clinical indication all matter.
Controlled energy delivery
CO₂ laser energy is delivered according to the selected treatment area and clinical protocol rather than applied as a general treatment for all symptoms.
Superficial tissue focus
Standard Nu-V treatment focuses on selected internal vaginal lining. External vulval treatment may be added as an optional extra where separately assessed and consented. The procedure does not directly repair deeper pelvic-floor muscle or fascial support.
Defined treatment area
Internal treatment, external treatment or a combined plan should only be selected after the relevant anatomy and treatment objective have been assessed.
Short clinic procedure
The Nu‑V treatment itself is typically around 15 minutes. Clinical consultation, preparation, consent and aftercare discussion are separate.
Important limitations
What Nu‑V does not do
It does not diagnose the cause of a symptom.
It does not strengthen pelvic-floor muscles.
It does not repair significant prolapse or deep structural separation.
It does not reverse menopause or ageing.
It does not guarantee vaginal tightening, lubrication or comfort.
It does not guarantee sexual, urinary or confidence-related outcomes.
Treatment objectives that may be discussed — without promising results
Depending on the clinical context, a woman may wish to discuss tissue quality, hydration, comfort, a feeling of mild laxity or another specific concern. These are discussion objectives, not promised results.
Whether CO₂ treatment has an appropriate evidence base for a specific objective must be considered separately during consent.
What happens during Nu‑V CO₂ treatment
The procedure is only one stage of the pathway. Assessment, informed consent and aftercare are equally important.
1. Private enquiry or introductory call
A free introductory call or private enquiry allows you to ask initial questions and understand the service. It is not the required clinical consultation and cannot confirm suitability.
2. Clinical consultation and assessment
Symptoms, medical history, screening context, likely causes, treatment objectives and relevant examination findings are reviewed.
3. Decision and informed consent
The evidence, uncertainty, possible risks, alternatives, treatment area, fees and limitations are explained before you decide whether to proceed.
4. Treatment and aftercare
Where appropriate, selected internal vaginal tissue is treated according to the clinical plan. Optional external vulval treatment may be added where separately assessed and consented. Written aftercare and contact guidance are provided.
During the procedure
What the Nu‑V session involves
The procedure uses a CO₂ laser system to deliver controlled energy to the treatment area identified during assessment.
Internal treatment
A clinical applicator may be used to treat selected areas of the vaginal lining according to the agreed plan.
External treatment
Selected external vulval tissue may be treated as an optional additional treatment where this has been separately assessed and included in the consented plan.
Treatment time
The Nu‑V procedure itself is typically around 15 minutes, although the total appointment is longer.
Comfort
Individual sensation varies. The clinician explains what may be felt and any appropriate comfort measures before treatment.
Different methods, different tissue targets
CO₂ laser is not the same as pelvic-floor therapy or surgery
These pathways may all be discussed in intimate healthcare, but they work in different ways and are not interchangeable.
Nu‑V CO₂ treatment
An energy-based procedure involving selected internal vaginal lining, with optional external vulval treatment where separately assessed and consented.
Pelvic-floor treatment
Assessment and rehabilitation of muscle function, coordination, strength and related symptoms.
Surgical assessment
Consideration of deeper structural repair where there is significant laxity, prolapse, muscle separation or perineal change.
For a wider overview of method categories, visit our vaginal rejuvenation guide.
Risks, recovery and aftercare
What to expect immediately after treatment
Written aftercare should distinguish expected temporary effects from symptoms that need clinical advice.
Expected temporary effects
Temporary warmth, irritation, swelling, spotting, watery discharge or discomfort may occur. Some women return to gentle daily activity soon after treatment.
Your clinician explains what is expected for the area treated and when to contact the clinic.
Material complications discussed during consent
Less common but more serious complications may include infection, thermal injury or burn, scarring, persistent pain, altered sensation or pain during intercourse.
The risk discussion must relate to the device, treatment area, clinical indication and individual medical context.
Short-term restrictions and contact guidance
You may be advised temporarily to avoid intercourse, tampons, swimming, hot tubs or baths, strenuous exercise and heavy lifting, and to use only aftercare products recommended by your clinician.
Your clinician will advise the appropriate restrictions and their duration based on your treatment and recovery. Contact the clinic if symptoms are worsening rather than improving or if you are concerned.
Response, review and maintenance
What outcomes may be discussed — and what cannot be promised
Treatment objectives are agreed individually. Response, timing and duration vary, and no vaginal, urinary, sexual or confidence-related result can be guaranteed.
Which objectives may be discussed?
Depending on the clinical context, discussion may include tissue quality, hydration, comfort, selected superficial tissue concerns or a feeling of mild laxity. These are treatment objectives, not promised results.
When might change be noticed, and how long might it last?
Any response and its timing vary. Duration is not guaranteed. Life stage, hormonal context, tissue characteristics, underlying cause and the treatment objective may all influence follow-up planning.
Is repeat treatment automatic?
No. A course or later maintenance should be discussed only where clinically appropriate and after reviewing response, risks and continuing goals.
What does the evidence for vaginal laser treatment mean?
Vaginal laser evidence cannot be reduced to a single statement that “laser works” or “laser does not work”. Research differs by indication, patient group, device, wavelength, settings, protocol, comparator, outcome measure and duration of follow-up.
Indication matters
Evidence concerning urogenital atrophy cannot automatically be applied to laxity, urinary symptoms, vulval treatment or another clinical objective.
Technology and protocol matter
CO₂ and other energy-based devices do not all use the same wavelength, tissue interaction, settings, treatment schedule or technique.
Study design matters
Uncontrolled improvement reports, observational studies and randomised sham-controlled trials provide different levels of certainty.
Current NICE position for urogenital atrophy
NICE HealthTech guidance 582 addresses transvaginal laser therapy specifically for urogenital atrophy. It states that evidence on long-term safety and efficacy is inadequate in quality and quantity and recommends that the procedure should only be used in the context of research for that indication.
The same guidance notes that the available evidence did not show short-term safety concerns, while still identifying inadequate long-term evidence.
Read NICE HTG582What this means for responsible treatment choice
CO₂ treatment should not be marketed as routine treatment for every vaginal, urinary, postpartum or menopause-related concern. Where it is discussed, consent should identify the precise treatment objective, the relevant evidence, uncertainty, possible risks, established alternatives and the possibility of little or no improvement.
Wording we avoid
Claims that overstate the method
Wording we use
Language that reflects informed choice
Method-specific page boundary
This page explains CO₂ treatment only
It does not duplicate the full menu of vaginal rejuvenation options. Different methods have different mechanisms, evidence, indications, risks and regulatory considerations.
Use the main vaginal rejuvenation guide when you need to compare wider medical, conservative, non-surgical and surgical pathways rather than research the Nu‑V CO₂ method specifically.
Visit the vaginal rejuvenation overviewRelated clinical pathways and evidence
Continue with the information most relevant to your concern
These links separate the Nu-V CO₂ method from broader vaginal rejuvenation, symptom-led assessment and established menopause or pelvic-health pathways.
Why the clinical pathway matters
An intimate CO₂ treatment should not begin with device selection alone. Safe care depends on assessment, clinician training, appropriate consent, a defined protocol and access to follow-up.
The Women’s Health Clinic approaches Nu‑V as one method within clinical decision-making rather than a universal wellness treatment.
Clinical reviewer
Dr Farzana Khan, MD, MRCGP, DFFP
This page is authored and medically reviewed by Dr Farzana Khan. Her clinical focus includes vaginal health, vaginal dryness and GSM, sexual-function concerns, lichen sclerosus, and selected intimate treatment pathways.
Assessment before device treatment
The presenting concern, relevant history, possible causes, contraindications and treatment alternatives are reviewed before a recommendation is made.
Treatment by an appropriate clinician
The treatment area, device settings, procedure plan and aftercare must be selected and delivered within the clinician’s training, competence and clinical protocol.
Consent that includes uncertainty
Consent should cover not only common temporary effects, but also evidence limitations, uncommon complications, alternatives and the possibility of little or no improvement.
Another route when needed
Where Nu‑V does not match the concern, we explain the limitation and discuss medical care, pelvic-floor support, further investigation or specialist referral as appropriate.
Written aftercare and contact guidance
Patients receive guidance about expected temporary effects, restrictions, warning signs and how to contact the clinic if they are concerned.
Review rather than automatic retreatment
Further treatment should follow review of response, continuing suitability and updated goals rather than being assumed from the outset.
Nu‑V CO₂ treatment pricing
Consultation and assessment are required before treatment
The free introductory call and the clinical consultation are different stages. Depending on your circumstances, the clinical consultation may be nurse-led or doctor-led. A consultation with Dr Farzana Khan is recommended for many women, particularly where symptoms are complex or more than one treatment pathway may need to be considered, but it is not mandatory for every Nu-V treatment. Treatment is booked only after suitability has been assessed.
Nurse-led Nu‑V
One treatment where this is considered appropriate after consultation and clinical assessment.
Single treatment fee
Nurse-led Nu‑V
A three-treatment package where a structured course is recommended following assessment.
£400 × 3 treatments
A package is not automatically required.
Nurse-led annual top-up
A later top-up may be discussed after review where continuing treatment remains suitable.
Annual top-up fee
Doctor-led treatment option
Nu‑V with a doctor
Doctor-led treatment fees differ from nurse-led treatment fees.
Single treatment
£799
Doctor-led
Triple package
£1,800
Doctor-led course
Annual top-up
£600
Doctor-led maintenance
Doctor-led consultation with Dr Farzana Khan
A consultation with Dr Farzana Khan is recommended for many women, particularly where symptoms are complex or more than one treatment pathway may need to be considered. It is not mandatory for every Nu-V treatment.
10-minute telephone consultation
Initial clinical consultation option
£45
20-minute face-to-face consultation
In-clinic clinical consultation
£150
How consultation fees are handled
If treatment is booked after consultation, booking and deposit terms are confirmed at the time of booking.
Please refer to our main pricing page for the latest consultation and treatment fees.
Where any deduction is applied
For a single treatment, any agreed deduction is applied to the treatment fee.
For a triple package, any agreed deduction is usually applied to the final treatment in the package.
Treatment fees apply only after clinical suitability has been confirmed.
Consultation and care
What matters during an intimate treatment journey
A responsible experience is not measured only by whether treatment is performed. Clarity, privacy, informed choice and appropriate follow-up matter throughout.
Women often value being able to describe an intimate concern without embarrassment, understand why a treatment may or may not fit, and make a decision without pressure. Individual treatment experiences and outcomes vary.
Respectful discussion
The starting point is a calm conversation about what has changed, what concerns you and what you hope to understand.
Clear clinical boundaries
You should understand what Nu‑V may reasonably be considered for, what it cannot achieve and when another route is more appropriate.
Support after the appointment
Written aftercare, warning signs and a clear route back to the clinic are important parts of the treatment process.
Nu-V CO₂ vaginal laser treatment FAQs
Residual questions about terminology, treatment areas, outcomes, evidence, risks, recovery and costs.
Nu-V is The Women’s Health Clinic’s name for an assessment-led internal CO₂ vaginal laser procedure. External vulval treatment may be added as an optional extra where clinically appropriate. Vaginal rejuvenation is a wider consumer term covering different medical, conservative, energy-based, injectable and surgical pathways. Nu-V is one method within that wider field.
CO₂ treatment does not directly strengthen pelvic-floor muscle or perform structural repair. It delivers controlled energy to selected superficial tissue with the intention of initiating a tissue response. It should not be presented as a guaranteed way to tighten vaginal walls.
Menopause-related dryness and GSM should be assessed properly, and established options such as lubricants, vaginal moisturisers and vaginal oestrogen where suitable should be discussed. NICE HTG582 remains cautious about transvaginal laser therapy for urogenital atrophy and recommends use only in the context of research because long-term safety and efficacy evidence is inadequate.
Urinary leakage and painful intercourse can have several causes. Pelvic-floor assessment, menopause care, treatment of infection or vulval disease, investigation, medical care or specialist referral may be more appropriate. Nu-V should not be presented as a universal or guaranteed treatment for either symptom.
Standard Nu-V treatment is internal vaginal treatment. External vulval treatment may be added as an optional extra where clinically appropriate, separately assessed and included in the consented plan.
The Nu-V procedure itself is typically around 15 minutes, although the total appointment is longer because preparation, confirmation of consent and aftercare discussion are separate. Individual sensation varies, so treatment should not be described as universally painless.
There is no single answer for everyone. A single treatment or structured course may be discussed only after assessment. Response, timing and duration vary, and later maintenance should follow review rather than being assumed automatically.
Temporary warmth, irritation, swelling, spotting, watery discharge or discomfort may occur. Less common complications may include infection, thermal injury or burn, scarring, persistent pain, altered sensation or pain during intercourse. Treatment may need to be delayed, avoided or referred where there is pregnancy, active infection, unexplained bleeding, an undiagnosed lesion, screening concerns, significant prolapse, severe unexplained pain or another medical contraindication.
A clinical consultation and assessment are required before treatment, but this does not always have to be with Dr Farzana Khan. Depending on your circumstances, the consultation may be nurse-led or doctor-led. A doctor-led consultation is recommended for many women, especially where symptoms are complex or different treatment options need to be considered. Current nurse-led and doctor-led prices are shown in the pricing section above and on the main pricing page.
Still deciding whether to enquire?
Start with a private conversation. You do not need to know whether Nu-V is the correct treatment before contacting the clinic.
Read expert women’s health articles
Explore our expert medical articles covering women’s health, menopause, intimate health and preventative care.
Katy Pitt Allen
Katy is a registered nurse in both the UK and Spain. She is an experienced gynaecological nurse and is…
Read MoreDr Cristina Signes
Cristina is a popular local gynaecologist who has been running clinics in Moraira and Javea for 4 years as…
Read MoreKaren Black
Karen Black is a Registered General Nurse and a Nurse Prescriber. She has been working in general practice…
Read MoreSarah Bienenstock
Sarah trained and qualified as a Registered Nurse Clinician in Canada. Her career began in breast cancer research…
Read MoreGuinevere Clark
Guinevere Clark has a background in nursing in A&E, PPI (Patient & Public Involvement) Research, Plastics/ENT Surgery and…
Read MoreTracey Withers
Tracey qualified as Registered Nurse in 2008, she was part of her local District Nursing Team for 2…
Read MoreRebecca Peak
Rebecca is practicing as an Oncology Clinical Nurse Specialist for 13 years and has a passion for Women’s…
Read MoreEllen Hart
Ellen has been a nurse for 15 years and has spent the last 10 years working in a…
Read MoreDelia McDermott
Delia has been qualified for 20 years and worked in different nursing fields until she realised it is…
Read MoreKeran Haughton
Keran has a wealth of nursing knowledge and experience. She started out in Urology where she first recognised…
Read MoreGaynor Owen
Gaynor is a registered nurse with a speciality in clinical care. Her experience really does put everyone at…
Read MoreEmma Louise
While awaiting a diagnosis for her own problems caused through childbirth, the urology nurse realised what was lacking…
Read MoreStill not sure where to start?
Browse the wider treatment pages or book a free consultation.
Browse our women’s health FAQs
Find clear answers to common questions about consultations, treatments, symptoms, preparation, aftercare and pricing.
